Suspected low-grade glioma: is deferring treatment safe?
about
Magnetic resonance perfusion for differentiating low grade from high grade gliomas at first presentationBiopsy versus resection for the management of low-grade gliomasBiopsy versus resection for the management of low-grade gliomasDiagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review.Neuroimaging in glioma therapy.Maximizing safe resection of low- and high-grade glioma.3'-Deoxy-3'-[(18)F]fluorothymidine and O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative StudyDoes early resection of presumed low-grade glioma improve survival? A clinical perspective.Postoperative radiotherapy of astrocytomas.Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas.Biopsy versus resection for the management of low-grade gliomas.Controversies in the therapy of low-grade glioma: when and how to treat.Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosisAdult low-grade glioma: 19-year experience at a single institution.Update on the therapeutic approaches to brain tumors.Surgery for low-grade gliomas: current evidence and controversies.Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.Oligodendroglial tumors.Proliferation and aneusomy predict survival of young patients with astrocytoma grade II.Effect of age on treatment decisions in low-grade glioma.Low-grade gliomas: management issues.Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic.Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.Applications of neural and mesenchymal stem cells in the treatment of gliomas.Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalitiesAssessment of nuclear size, nuclear DNA content and proliferation index in stereotaxic biopsies from brain tumours.Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery.Radial expansion rates and tumor growth kinetics predict malignant transformation in contrast-enhancing low-grade diffuse astrocytoma.Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors.Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy.Role of surgical resection in low- and high-grade gliomas.Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival.Management of primary brain tumors--1996.Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.The preoperative use of navigated transcranial magnetic stimulation facilitates early resection of suspected low-grade gliomas in the motor cortex.Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors.Glial microtumor with 17-year of postoperative follow up.Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors.
P2860
Q24187505-C7BBFFBD-7A16-4FD1-976F-D2326F9400C6Q24197750-164A3648-A9A9-4BBE-843F-99136A35FACAQ24234687-70FB51E9-5F9C-4365-AE51-F08EEE5256A0Q30680698-47953284-7B74-4543-8E79-D176BC0A7675Q30988178-6D10B751-9449-4D74-B7C7-1103507081C1Q31095748-90430C82-7E21-48EF-9DC6-4CEBA86705FAQ33704202-3C3A7ADF-DD90-4FFB-8576-419EF91D3D78Q33867304-98FA2F86-21C7-4769-AA53-B83C4A466CE5Q34210447-1FCAACAA-5EEF-4D71-8567-7D87D115BBEAQ34390352-D4608754-68A7-4313-B6AA-BF3354C0B245Q34555925-AC1FBD6F-FD4D-476A-981E-A2A18D93A98BQ34969223-9AD276BA-9E69-4248-9870-A5B9C198FB41Q35038477-D2B70931-EDE0-4587-960D-5EE2837A3DCDQ35183129-EDB28876-EC7F-4211-B7CF-D551CF614CF1Q35576174-0ACB86A5-7AED-4911-A928-48527717CD27Q36307787-D4BF31F7-1857-4F87-A522-95EFD62FA1ECQ36318219-BFBAFC28-AADE-40F7-B2F5-137E405B6D95Q36453277-83446175-7AF7-44D9-8BAF-5BFC978413D4Q36670841-F60D449C-73F9-4D0B-BD93-003E3ED7226AQ36758794-5AF04DA7-F4D9-4ED0-873C-EC2E74C52374Q37030794-DCEA14BF-0620-41CA-AE02-066087803807Q37344962-065D8E02-4473-4F5F-8190-25290A6028BDQ37462007-9A7F329D-EA13-4379-823E-43FB01050CB3Q37483966-6F5FDDB1-7283-4317-90EE-D6E57195BCCDQ38055317-7478341D-951C-4109-A239-26E08BB17C66Q39398417-4D5AE8EC-865D-4AE3-836C-BE3B5A5A9705Q41354879-5792F26F-9886-4841-BD7F-01E1307C7D72Q41850051-8F717F51-06D0-4E15-B763-B17C08EA3D34Q42011021-593B68BD-F68E-4ED6-92FC-7C37820D9F70Q44453455-7B47CDC7-0DAE-44D5-BC51-6F4289D8AD7CQ46723190-42832645-456E-45D8-BC22-A147EB49C55AQ48119215-36AE3CEE-577B-4C96-8448-A2276526C65BQ48455096-96E8C999-9F59-44D7-933A-48A34B3D1E67Q48520992-55BFA187-FC57-468A-A509-2DB9AEE6A17EQ49087518-D120F7AD-59BB-494B-80E3-FF824654186EQ50907799-A93A7FA6-E120-4A30-988E-CE53C51B78ECQ50977755-EC0FECE1-2349-4518-AA11-004578E75881Q55463486-C345AE7C-13D6-42F2-8520-A0400993B449Q55470597-A7D078B0-1BB1-4AC4-B2FD-E42DEC7D7D97
P2860
Suspected low-grade glioma: is deferring treatment safe?
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Suspected low-grade glioma: is deferring treatment safe?
@en
Suspected low-grade glioma: is deferring treatment safe?
@nl
type
label
Suspected low-grade glioma: is deferring treatment safe?
@en
Suspected low-grade glioma: is deferring treatment safe?
@nl
prefLabel
Suspected low-grade glioma: is deferring treatment safe?
@en
Suspected low-grade glioma: is deferring treatment safe?
@nl
P2093
P2860
P356
P1433
P1476
Suspected low-grade glioma: is deferring treatment safe?
@en
P2093
P2860
P304
P356
10.1002/ANA.410310413
P577
1992-04-01T00:00:00Z